DNA X, Inc. (SONM)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $50.92M | $93.63M | $69.83M | $54.57M | $63.99M | $116.25M | $135.66M | — |
| Cost of Revenue | — | $48.38M | $74.31M | $58.20M | $48.16M | $48.78M | $81.74M | $87.58M | — |
| Gross Profit | — | $9.92M | $19.32M | $11.62M | $6.41M | $15.21M | $34.51M | $48.09M | — |
| Operating Income | -$5.41M | -$3.10M | $513.0K | -$14.29M | -$38.00M | -$29.26M | -$22.38M | $5.39M | — |
| Net Income | -$20.66M | -$33.65M | -$90.0K | -$14.09M | -$38.63M | -$29.93M | -$25.83M | $1.28M | — |
| EPS (Diluted) | $-28.58 | $-128.37 | $-0.02 | $-0.49 | $-4.08 | — | — | — | — |
| Total Assets | $43.90M | $39.74M | $56.04M | $53.69M | $41.09M | $50.31M | $55.46M | $67.34M | — |
| Total Liabilities | $50.62M | $45.44M | $33.67M | $33.64M | $22.46M | $21.90M | $29.93M | $62.22M | — |
| Shareholders' Equity | -$7.96M | -$5.70M | $22.37M | $20.05M | $18.63M | $28.41M | $25.52M | $5.13M | -$89.91M |
| Cash & Equivalents | $1.30M | $5.34M | $9.40M | $13.21M | $11.23M | $22.14M | $11.30M | $13.05M | — |
| Operating Cash Flow | -$23.53M | -$8.49M | -$4.05M | -$12.36M | -$38.48M | -$10.56M | -$33.52M | $3.86M | — |
| Capital Expenditures | — | $214.0K | $36.0K | $8.0K | $46.0K | $11.0K | $992.0K | $787.0K | — |
| Shares Outstanding | 1.27M | 276.9K | 4.43M | 40.77M | 18.81M | 6.63M | 20.44M | 15.59M | — |